Targeting aberrant splicing

被引：0

作者：

Anna Dart

机构：

[1] Nature Reviews Cancer,

来源：

Nature Reviews Cancer | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Bland et al. show that cancer types with heterozygous somatic hotspot mutations in the spliceosome component SF3B1 are vulnerable to PARP inhibition, which causes a defective response to replication stress.

引用

页码：653 / 653

共 50 条

[1] Targeting aberrant splicing
Dart, Anna
[J]. NATURE REVIEWS CANCER, 2023, 23 (10) : 653 - 653
[2] Understanding and Targeting Aberrant RNA Splicing in Leukemias
Yoshimi, Akihide
[J]. CANCER SCIENCE, 2023, 114 : 1556 - 1556
[3] Understanding and Targeting Aberrant RNA Splicing in Cancers
Yoshimi, Akihide
[J]. CANCER SCIENCE, 2023, 114 : 1514 - 1514
[4] Understanding and Targeting Aberrant mRNA splicing in tumorigenesis
Yoshimi, Akihide
[J]. CANCER SCIENCE, 2021, 112 : 172 - 172
[5] TARGETING ABERRANT SPLICING IN PEDIATRIC ACUTE MYELOID LEUKEMIA
Klusmann, Jan-Henning
Laszig, Stephanie
Dias, Jose Goncelves
Schuschel, Konstantin
Knapp, Stefan
Reinhardt, Dirk
Bhayadia, Raj
Heckl, Dirk
[J]. EXPERIMENTAL HEMATOLOGY, 2024, 137
[6] A NEW STRATEGY OF CANCER GENE THERAPY TARGETING ABERRANT SPLICING
Okuma, A.
[J]. CYTOTHERAPY, 2022, 24 (05) : S145 - S145
[7] Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing
Li, Dianyang
Yu, Wenying
Lai, Maode
[J]. DRUG DISCOVERY TODAY, 2023, 28 (09)
[8] Targeting Aberrant Splicing in Myelodysplastic Syndromes Biologic Rationale and Clinical Opportunity
Brunner, Andrew M.
Steensma, David P.
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (02) : 379 - +
[9] Normal and aberrant splicing of LMNA
Luo, Yue-Bei
Mastaglia, Frank L.
Wilton, Steve D.
[J]. JOURNAL OF MEDICAL GENETICS, 2014, 51 (04) : 215 - 223
[10] Aberrant and alternative splicing in cancer
Venables, JP
[J]. CANCER RESEARCH, 2004, 64 (21) : 7647 - 7654

← 1 2 3 4 5 →